Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Vitamin D | 10 | 2013 | 261 | 2.540 |
Why?
|
Receptors, Calcitriol | 6 | 2015 | 129 | 2.000 |
Why?
|
Renin-Angiotensin System | 7 | 2013 | 133 | 1.520 |
Why?
|
Signal Transduction | 6 | 2015 | 3241 | 1.040 |
Why?
|
Kidney Diseases | 4 | 2013 | 418 | 0.990 |
Why?
|
Cardiovascular Diseases | 3 | 2013 | 827 | 0.770 |
Why?
|
Inflammation | 2 | 2015 | 920 | 0.660 |
Why?
|
Vitamin D Deficiency | 4 | 2012 | 103 | 0.620 |
Why?
|
Podocytes | 2 | 2013 | 30 | 0.500 |
Why?
|
Receptor, TIE-2 | 1 | 2013 | 15 | 0.480 |
Why?
|
Angiopoietin-2 | 1 | 2013 | 15 | 0.470 |
Why?
|
Acute Lung Injury | 1 | 2013 | 60 | 0.450 |
Why?
|
Gastrointestinal Tract | 1 | 2015 | 191 | 0.440 |
Why?
|
Diabetic Nephropathies | 3 | 2011 | 248 | 0.430 |
Why?
|
Vitamins | 2 | 2009 | 81 | 0.410 |
Why?
|
Renin | 3 | 2007 | 79 | 0.410 |
Why?
|
Blood Pressure | 3 | 2007 | 1143 | 0.410 |
Why?
|
Cardiovascular System | 1 | 2012 | 71 | 0.400 |
Why?
|
Intestinal Mucosa | 2 | 2015 | 797 | 0.390 |
Why?
|
Epithelial Cells | 1 | 2015 | 669 | 0.380 |
Why?
|
Immunity, Innate | 1 | 2013 | 409 | 0.370 |
Why?
|
Calcitriol | 3 | 2013 | 174 | 0.360 |
Why?
|
Protective Agents | 1 | 2009 | 33 | 0.350 |
Why?
|
MicroRNAs | 1 | 2013 | 534 | 0.330 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2015 | 549 | 0.320 |
Why?
|
Kidney | 2 | 2012 | 1241 | 0.300 |
Why?
|
Gene Expression Regulation | 2 | 2013 | 1920 | 0.290 |
Why?
|
Hypertension | 4 | 2007 | 1141 | 0.260 |
Why?
|
Animals | 11 | 2015 | 26582 | 0.260 |
Why?
|
Antihypertensive Agents | 1 | 2007 | 521 | 0.220 |
Why?
|
S100 Calcium Binding Protein G | 1 | 2001 | 22 | 0.210 |
Why?
|
Gene Expression | 2 | 2002 | 1284 | 0.190 |
Why?
|
Mice | 5 | 2013 | 11352 | 0.170 |
Why?
|
Mice, Knockout | 3 | 2013 | 1924 | 0.160 |
Why?
|
Humans | 12 | 2015 | 86645 | 0.150 |
Why?
|
Calcium | 1 | 2001 | 1156 | 0.140 |
Why?
|
Models, Biological | 2 | 2011 | 1749 | 0.120 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 20 | 0.120 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2013 | 121 | 0.120 |
Why?
|
Capillary Permeability | 1 | 2013 | 130 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2013 | 154 | 0.110 |
Why?
|
Gene Deletion | 1 | 2013 | 329 | 0.110 |
Why?
|
Lipopolysaccharides | 1 | 2013 | 286 | 0.110 |
Why?
|
Endocrine System | 1 | 2011 | 17 | 0.100 |
Why?
|
Intestines | 1 | 2015 | 411 | 0.100 |
Why?
|
Kidney Tubules | 1 | 2011 | 94 | 0.100 |
Why?
|
Endothelial Cells | 1 | 2013 | 428 | 0.100 |
Why?
|
Ultraviolet Rays | 1 | 2011 | 193 | 0.090 |
Why?
|
Atherosclerosis | 1 | 2013 | 244 | 0.090 |
Why?
|
Macrophages | 1 | 2013 | 554 | 0.090 |
Why?
|
Risk | 1 | 2011 | 674 | 0.090 |
Why?
|
Homeostasis | 1 | 2011 | 409 | 0.090 |
Why?
|
Treatment Outcome | 2 | 2012 | 7993 | 0.080 |
Why?
|
Vacuolar Proton-Translocating ATPases | 1 | 2007 | 19 | 0.080 |
Why?
|
Fumarates | 1 | 2007 | 26 | 0.080 |
Why?
|
Amides | 1 | 2007 | 60 | 0.080 |
Why?
|
Lung | 1 | 2013 | 1170 | 0.080 |
Why?
|
Drug Design | 1 | 2007 | 124 | 0.070 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2007 | 90 | 0.070 |
Why?
|
Apoptosis | 1 | 2013 | 1683 | 0.070 |
Why?
|
Molecular Structure | 1 | 2007 | 287 | 0.070 |
Why?
|
Receptors, Cell Surface | 1 | 2007 | 286 | 0.070 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 231 | 0.070 |
Why?
|
Kidney Failure, Chronic | 1 | 2011 | 509 | 0.070 |
Why?
|
Antibodies | 1 | 2007 | 350 | 0.070 |
Why?
|
Phenotype | 1 | 2011 | 2378 | 0.060 |
Why?
|
Enzyme Inhibitors | 1 | 2007 | 639 | 0.060 |
Why?
|
Peptides | 1 | 2007 | 639 | 0.060 |
Why?
|
Sodium, Dietary | 1 | 2002 | 13 | 0.050 |
Why?
|
Drinking Behavior | 1 | 2002 | 13 | 0.050 |
Why?
|
Hypocalcemia | 1 | 2002 | 41 | 0.050 |
Why?
|
Angiotensin II | 1 | 2002 | 94 | 0.050 |
Why?
|
Neuropeptides | 1 | 2002 | 112 | 0.050 |
Why?
|
Calbindins | 1 | 2001 | 19 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2001 | 63 | 0.050 |
Why?
|
Blotting, Northern | 1 | 2001 | 256 | 0.050 |
Why?
|
Phosphorus | 1 | 2001 | 118 | 0.050 |
Why?
|
Intestinal Absorption | 1 | 2001 | 124 | 0.050 |
Why?
|
In Vitro Techniques | 1 | 2002 | 989 | 0.050 |
Why?
|
Creatinine | 1 | 2001 | 338 | 0.050 |
Why?
|
Blotting, Western | 1 | 2001 | 782 | 0.040 |
Why?
|
Trans-Activators | 1 | 2002 | 429 | 0.040 |
Why?
|
Promoter Regions, Genetic | 1 | 2002 | 937 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2002 | 1981 | 0.040 |
Why?
|